NA Bladder Disorders Market - Industry Trends and Forecast to 2029

NA Bladder Disorders Market - Industry Trends and Forecast to 2029

The North America bladder disorders market is projected to register a substantial CAGR of 11.8% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2020, and the forecast period is 2022 to 2029

Market Segmentation
North America Bladder disorders Market - By Type (Cystitis, Urinary Incontinence, Overactive Bladder, Interstitial Cystitis, Bladder Cancer), Treatment Type (Surgery, Medication, Non-surgical), End User (Hospitals, Clinics, Ambulatory Surgery Centres, Others), Distribution Channel (Direct, Retail), Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2029

Some of the major factors contributing to the growth of the North America bladder disorders market are:
• Rising R&D investments and Launch of novel therapies in upcoming years
• Growing technological advancement
• Growing geriatric population
• Strategic initiatives adopted by market players

Market Players

The major companies which are operating in the North America bladder disorders market are listed below:
The North America bladder disorders market is projected to register a substantial CAGR of 11.8% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2020, and the forecast period is 2022 to 2029

Market Segmentation
North America Bladder disorders Market - By Type (Cystitis, Urinary Incontinence, Overactive Bladder, Interstitial Cystitis, Bladder Cancer), Treatment Type (Surgery, Medication, Non-surgical), End User (Hospitals, Clinics, Ambulatory Surgery Centres, Others), Distribution Channel (Direct, Retail), Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2029

Some of the major factors contributing to the growth of the North America bladder disorders market are:
• Rising R&D investments and Launch of novel therapies in upcoming years
• Growing technological advancement
• Growing geriatric population
• Strategic initiatives adopted by market players

Market Players

The major companies which are operating in the North America bladder disorders market are listed below:
• Medtronic
• Laborie
• Boston Scientific Corporation
• Pfizer Inc.
• Astellas Pharma Inc.
• KYORIN Pharmaceutical Co., Ltd. (A subsidiary of KYORIN Holdings, Inc.)
• Bristol-Myers Squibb Company
• Johnson & Johnson Services, Inc.
• Axonics, Inc.
• Merck & Co., Inc.
• Viatris Inc.
• Blue Wind Medical
• Valencia Technologies
• Gaylord Chemical Company, L.L.C.
• Coloplast Corp, AbbVie Inc.
• Sun Pharmaceutical Industries Ltd.
• Zydus Group
• Urovant Sciences, among others.


Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.